Company Filing History:
Years Active: 2025
Title: Innovations in Cancer Treatment by Padma Kadiyala
Introduction
Padma Kadiyala is an accomplished inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic protein-based nanoparticles. Her work focuses on creating effective solutions for treating intracranial tumors, showcasing her dedication to advancing medical science.
Latest Patents
Kadiyala holds a patent for "Therapeutic protein-based nanoparticles for treating cancer." This invention involves protein-based nanoparticles designed specifically for treating cancer, particularly intracranial tumors. The nanoparticles are characterized by a water-soluble protein with an average molecular weight ranging from ≥about 8 kDa to ≤about 700 kDa. In certain variations, the protein is cross-linked, forming a mesh structure with an average linear mesh size of ≥about 1 nm to ≤about 4 nm. Additionally, these nanoparticles may incorporate a transcription factor, such as a therapeutic nucleic acid, within the mesh structure. The methods for creating these nanoparticles include jetting a liquid containing the water-soluble protein through a nozzle and exposing it to an electric field to solidify the liquid.
Career Highlights
Kadiyala is affiliated with the University of Michigan, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer therapies, particularly in enhancing the effectiveness of treatment options available to patients.
Collaborations
Throughout her career, Kadiyala has collaborated with notable colleagues, including Joerg Lahann and Nahal Habibi. These partnerships have contributed to her innovative research and the advancement of her patented technologies.
Conclusion
Padma Kadiyala's contributions to the field of cancer treatment through her patented innovations highlight her role as a leading inventor in medical science. Her work with therapeutic protein-based nanoparticles represents a significant step forward in the fight against cancer.